{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T01:46:44Z","timestamp":1790646404003,"version":"4.1.0"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,8,25]],"date-time":"2022-08-25T00:00:00Z","timestamp":1661385600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,8,25]],"date-time":"2022-08-25T00:00:00Z","timestamp":1661385600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100011096","name":"Jazz Pharmaceuticals","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100011096","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Neurol"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Excessive daytime sleepiness (EDS) is a cardinal symptom of narcolepsy and affects many patients with obstructive sleep apnoea (OSA). EDS is associated with reduced quality of life, increased accident risk, and poor workplace performance. Given the impact of EDS, the ability to predict health-related utility from sleepiness is valuable for examining the cost effectiveness of novel treatments. The aim of this study was to examine the association between EDS and EQ-5D in patients with OSA and\/or narcolepsy by modelling EQ-5D utility scores from Epworth Sleepiness Scale (ESS) scores.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>Data were obtained from the Europe 2016\/2017 National Health and Wellness Survey, an online, general population survey, designed to represent the age and gender composition of each country\u2019s adult population. Analyses included 2,348 patients self-reporting symptomatic and diagnosed OSA (<jats:italic>n<\/jats:italic>\u2009=\u20092,277), narcolepsy (<jats:italic>n<\/jats:italic>\u2009=\u200948), or both (<jats:italic>n<\/jats:italic>\u2009=\u200923). Multivariable models were used to examine ESS as a predictor of EQ-5D utility while adjusting for covariates of interest. Results were validated following the National Institute for Health and Care Excellence Decision Support Unit guidelines for predictive modelling.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Utility decreased as EDS severity increased (no EDS: 0.711\u2009\u00b1\u20090.251, mild: 0.685\u2009\u00b1\u20090.261, moderate: 0.643\u2009\u00b1\u20090.268, severe: 0.559\u2009\u00b1\u20090.323). Whereas participants with only OSA or only narcolepsy did not differ in utility, those with both conditions had lower scores (0.685\u2009\u00b1\u20090.266 and 0.627\u2009\u00b1\u20090.325 vs. 0.439\u2009\u00b1\u20090.340, respectively). Piecewise linear regression identified a single breakpoint at ESS score of 11.29. In the final model, for each point increase in ESS score, the corresponding decrease in EQ-5D utility was larger among patients with ESS scores\u2009\u2265\u200912 compared to patients with ESS scores\u2009\u2264\u200911 (model slopes: -0.0131 vs. -0.0026, respectively). Findings from the validation sample confirmed these results.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>This study demonstrates the impact of sleepiness on quality of life (QoL) and its negative impact irrespective of sleep condition (OSA or narcolepsy). The breakpoint identified is relatively consistent with the established ESS cutoff score\u2009\u2265\u200911, which demarcates pathological sleepiness. Furthermore, as EDS severity worsens (increases) on the ESS, the impact on QoL is greater.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12883-022-02827-7","type":"journal-article","created":{"date-parts":[[2022,8,25]],"date-time":"2022-08-25T09:04:34Z","timestamp":1661418274000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Examining the impact of excessive daytime sleepiness on utility scores in patients with obstructive sleep apnoea and\/or narcolepsy in five European countries"],"prefix":"10.1186","volume":"22","author":[{"given":"M. Janelle","family":"Cambron-Mellott","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3656-4089","authenticated-orcid":false,"given":"Sam","family":"Mettam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vicky W.","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John C.","family":"Rowland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"JeanPierre Coaquira","family":"Castro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,8,25]]},"reference":[{"key":"2827_CR1","doi-asserted-by":"crossref","unstructured":"Mahmood M, Kushida CA. Excessive daytime sleepiness. In: Montagna P, Chokroverty S, eds. Handbook of Clinical Neurology. Vol 99. San Francisco: Elsevier; 2011:825\u201331.","DOI":"10.1016\/B978-0-444-52007-4.00009-6"},{"issue":"2","key":"2827_CR2","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/j.smrv.2008.01.001","volume":"12","author":"MM Ohayon","year":"2008","unstructured":"Ohayon MM. From wakefulness to excessive sleepiness: what we know and still need to know. Sleep Med Rev. 2008;12(2):129\u201341.","journal-title":"Sleep Med Rev"},{"issue":"8","key":"2827_CR3","doi-asserted-by":"publisher","first-page":"1482","DOI":"10.1093\/brain\/124.8.1482","volume":"124","author":"C Guilleminault","year":"2001","unstructured":"Guilleminault C, Brooks SN. Excessive daytime sleepiness: a challenge for the practising neurologist. Brain. 2001;124(8):1482\u201391.","journal-title":"Brain"},{"issue":"9","key":"2827_CR4","first-page":"26","volume":"4","author":"D McWhirter","year":"2007","unstructured":"McWhirter D, Bae C, Budur K. The assessment, diagnosis, and treatment of excessive sleepiness: practical considerations for the psychiatrist. Psychiatry (Edgmont). 2007;4(9):26\u201335.","journal-title":"Psychiatry (Edgmont)"},{"issue":"1","key":"2827_CR5","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1378\/chest.14-1304","volume":"148","author":"Z Khan","year":"2015","unstructured":"Khan Z, Trotti LM. Central disorders of hypersomnolence. Chest. 2015;148(1):262\u201373.","journal-title":"Chest"},{"key":"2827_CR6","volume-title":"International classification of sleep disorders","author":"American Academy of Sleep Medicine","year":"2014","unstructured":"American Academy of Sleep Medicine. International classification of sleep disorders. 3rd ed. Darien: American Academy of Sleep Medicine; 2014.","edition":"3"},{"issue":"2","key":"2827_CR7","first-page":"5","volume":"41","author":"Z Zachariev","year":"1999","unstructured":"Zachariev Z, Djurkova A. Clinico-polysomnographic diagnostics of narcolepsy-cataplexy. Folia Med. 1999;41(2):5\u201312.","journal-title":"Folia Med"},{"issue":"3","key":"2827_CR8","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/0163-8343(90)90078-Q","volume":"12","author":"LD Rosenthal","year":"1990","unstructured":"Rosenthal LD, Merlotti L, Young DK, Zorick FJ, Wittig RM, Roehrs TA, et al. Subjective and polysomnographic characteristics of patients diagnosed with narcolepsy. Gen Hosp Psychiatry. 1990;12(3):191\u20137.","journal-title":"Gen Hosp Psychiatry"},{"issue":"9","key":"2827_CR9","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1038\/s41582-019-0226-9","volume":"15","author":"CLA Bassetti","year":"2019","unstructured":"Bassetti CLA, Adamantidis A, Burdakov D, Han F, Gay S, Kallweit U, et al. Narcolepsy - clinical spectrum, aetiopathophysiology, diagnosis and treatment. Nat Rev Neurol. 2019;15(9):519\u201339.","journal-title":"Nat Rev Neurol"},{"issue":"2","key":"2827_CR10","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1513\/pats.200709-155MG","volume":"5","author":"NM Punjabi","year":"2008","unstructured":"Punjabi NM. The epidemiology of adult obstructive sleep apnea. Proc Am Thorac Soc. 2008;5(2):136\u201343.","journal-title":"Proc Am Thorac Soc"},{"issue":"8","key":"2827_CR11","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1016\/S2213-2600(19)30198-5","volume":"7","author":"AV Benjafield","year":"2019","unstructured":"Benjafield AV, Ayas NT, Eastwood PR, Heinzer R, Ip MS, Morrell MJ, et al. Estimation of the global prevalence and burden of obstructive sleep apnoea: a literature-based analysis. Lancet Respir Med. 2019;7(8):687\u201398.","journal-title":"Lancet Respir Med"},{"issue":"1 pt 2","key":"2827_CR12","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1111\/j.1365-2869.2010.00861.x","volume":"20","author":"H Hrubos-str\u00f8m","year":"2011","unstructured":"Hrubos-str\u00f8m H, Randby A, Namtvedt SK, Kristiansen HA, Einvik G, Benth J, et al. A Norwegian population-based study on the risk and prevalence of obstructive sleep apnea. The Akershus Sleep Apnea Project (ASAP). J Sleep Res. 2011;20(1 pt 2):162\u201370.","journal-title":"J Sleep Res"},{"issue":"3","key":"2827_CR13","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1164\/ajrccm.163.3.2005065","volume":"163","author":"J Dur\u00e1n","year":"2001","unstructured":"Dur\u00e1n J, Esnaola S, Rubio R, Iztueta \u00c1. Obstructive sleep apnea\u2013hypopnea and related clinical features in a population-based sample of subjects aged 30 to 70 yr. Am J Respir Crit Care Med. 2001;163(3):685\u20139.","journal-title":"Am J Respir Crit Care Med"},{"issue":"1","key":"2827_CR14","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1111\/j.1365-2869.2008.00632.x","volume":"17","author":"R P\u0142ywaczewski","year":"2008","unstructured":"P\u0142ywaczewski R, Bednarek M, Jonczak L, Zieli\u0144ski J. Sleep-disordered breathing in a middle-aged and older Polish urban population. J Sleep Res. 2008;17(1):73\u201381.","journal-title":"J Sleep Res"},{"issue":"1","key":"2827_CR15","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1183\/13993003.01148-2015","volume":"47","author":"ES Arnardottir","year":"2016","unstructured":"Arnardottir ES, Bjornsdottir E, Olafsdottir KA, Benediktsdottir B, Gislason T. Obstructive sleep apnoea in the general population: highly prevalent but minimal symptoms. Eur Respir J. 2016;47(1):194\u2013202.","journal-title":"Eur Respir J"},{"issue":"5","key":"2827_CR16","doi-asserted-by":"publisher","first-page":"e12770","DOI":"10.1111\/jsr.12770","volume":"28","author":"I Fietze","year":"2019","unstructured":"Fietze I, Laharnar N, Obst A, Ewert R, Felix SB, Garcia C, et al. Prevalence and association analysis of obstructive sleep apnea with gender and age differences\u2013Results of SHIP-Trend. J Sleep Res. 2019;28(5):e12770.","journal-title":"J Sleep Res"},{"issue":"4","key":"2827_CR17","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1016\/S2213-2600(15)00043-0","volume":"3","author":"R Heinzer","year":"2015","unstructured":"Heinzer R, Vat S, Marques-Vidal P, Marti-Soler H, Andries D, Tobback N, et al. Prevalence of sleep-disordered breathing in the general population: the HypnoLaus study. Lancet Respir Med. 2015;3(4):310\u20138.","journal-title":"Lancet Respir Med"},{"issue":"4","key":"2827_CR18","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1111\/jsr.12039","volume":"22","author":"M Gasa","year":"2013","unstructured":"Gasa M, Tamisier R, Launois SH, Sapene M, Martin F, Stach B, et al. Residual sleepiness in sleep apnea patients treated by continuous positive airway pressure. J Sleep Res. 2013;22(4):389\u201397.","journal-title":"J Sleep Res"},{"issue":"6","key":"2827_CR19","first-page":"608","volume":"4","author":"G Slater","year":"2012","unstructured":"Slater G, Steier J. Excessive daytime sleepiness in sleep disorders. J Thorac Dis. 2012;4(6):608.","journal-title":"J Thorac Dis"},{"issue":"3","key":"2827_CR20","doi-asserted-by":"publisher","first-page":"401","DOI":"10.5664\/jcsm.5594","volume":"12","author":"NM Flores","year":"2016","unstructured":"Flores NM, Villa KF, Black J, Chervin RD, Witt EA. The humanistic and economic burden of narcolepsy. J Clin Sleep Med. 2016;12(3):401\u20137.","journal-title":"J Clin Sleep Med"},{"issue":"12","key":"2827_CR21","doi-asserted-by":"publisher","first-page":"1377","DOI":"10.5664\/jcsm.5268","volume":"11","author":"LJ Kim","year":"2015","unstructured":"Kim LJ, Coelho FM, Hirotsu C, Araujo P, Bittencourt L, Tufik S, et al. Frequencies and associations of narcolepsy-related symptoms: a cross-sectional study. J Clin Sleep Med. 2015;11(12):1377\u201384.","journal-title":"J Clin Sleep Med"},{"issue":"5","key":"2827_CR22","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1016\/j.sleep.2004.04.003","volume":"5","author":"L Vignatelli","year":"2004","unstructured":"Vignatelli L, D\u2019Alessandro R, Mosconi P, Ferini-Strambi L, Guidolin L, De Vincentiis A, et al. Health-related quality of life in Italian patients with narcolepsy: the SF-36 health survey. Sleep Med. 2004;5(5):467\u201375.","journal-title":"Sleep Med"},{"issue":"1","key":"2827_CR23","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.sleep.2010.07.008","volume":"12","author":"L Vignatelli","year":"2011","unstructured":"Vignatelli L, Plazzi G, Peschechera F, Delaj L, D\u2019Alessandro R. A 5-year prospective cohort study on health-related quality of life in patients with narcolepsy. Sleep Med. 2011;12(1):19\u201323.","journal-title":"Sleep Med"},{"issue":"6","key":"2827_CR24","doi-asserted-by":"publisher","first-page":"636","DOI":"10.1136\/jnnp.2008.161588","volume":"80","author":"Y Dauvilliers","year":"2009","unstructured":"Dauvilliers Y, Paquereau J, Bastuji H, Drouot X, Weil J-S, Viot-Blanc V. Psychological health in central hypersomnias: the French Harmony study. J Neurol Neurosurg Psychiatry. 2009;80(6):636\u201341.","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"12","key":"2827_CR25","doi-asserted-by":"publisher","first-page":"1517","DOI":"10.1080\/14656566.2021.1915987","volume":"22","author":"G Pellitteri","year":"2021","unstructured":"Pellitteri G, de Biase S, Valente M, Gigli GL. How treatable is narcolepsy with current pharmacotherapy and what does the future hold? Expert Opin Pharmacother. 2021;22(12):1517\u201320.","journal-title":"Expert Opin Pharmacother"},{"issue":"7","key":"2827_CR26","doi-asserted-by":"publisher","first-page":"772","DOI":"10.1080\/00325481.2021.1948305","volume":"133","author":"R Rosenberg","year":"2021","unstructured":"Rosenberg R, Schweitzer PK, Steier J, Pepin JL. Residual excessive daytime sleepiness in patients treated for obstructive sleep apnea: guidance for assessment, diagnosis, and management. Postgrad Med. 2021;133(7):772\u201383.","journal-title":"Postgrad Med"},{"issue":"4","key":"2827_CR27","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1164\/rccm.201808-1509OC","volume":"200","author":"DR Mazzotti","year":"2019","unstructured":"Mazzotti DR, Keenan BT, Lim DC, Gottlieb DJ, Kim J, Pack AI. Symptom subtypes of obstructive sleep apnea predict incidence of cardiovascular outcomes. Am J Respir Crit Care Med. 2019;200(4):493\u2013506.","journal-title":"Am J Respir Crit Care Med"},{"issue":"1","key":"2827_CR28","doi-asserted-by":"publisher","first-page":"105","DOI":"10.5664\/jcsm.5406","volume":"12","author":"E Bj\u00f6rnsd\u00f3ttir","year":"2016","unstructured":"Bj\u00f6rnsd\u00f3ttir E, Benediktsd\u00f3ttir B, Pack AI, Arnardottir ES, Kuna ST, G\u00edslason T, et al. The prevalence of depression among untreated obstructive sleep apnea patients using a standardized psychiatric interview. J Clin Sleep Med. 2016;12(1):105\u201312.","journal-title":"J Clin Sleep Med"},{"issue":"10","key":"2827_CR29","doi-asserted-by":"publisher","first-page":"834","DOI":"10.1136\/thx.2009.115105","volume":"64","author":"PE Ronksley","year":"2009","unstructured":"Ronksley PE, Hemmelgarn BR, Heitman SJ, Hanly PJ, Faris PD, Quan H, et al. Obstructive sleep apnoea is associated with diabetes in sleepy subjects. Thorax. 2009;64(10):834\u20139.","journal-title":"Thorax"},{"issue":"1","key":"2827_CR30","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.sleep.2007.01.009","volume":"9","author":"A Mulgrew","year":"2007","unstructured":"Mulgrew A, Ryan C, Fleetham J, Cheema R, Fox N, Koehoorn M, et al. The impact of obstructive sleep apnea and daytime sleepiness on work limitation. Sleep Med. 2007;9(1):42\u201353.","journal-title":"Sleep Med"},{"issue":"3","key":"2827_CR31","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1093\/sleep\/34.3.363","volume":"34","author":"PE Ronksley","year":"2011","unstructured":"Ronksley PE, Hemmelgarn BR, Heitman SJ, Ward FW, Ghali WA, Manns B, et al. Excessive daytime sleepiness is associated with increased health care utilization among patients referred for assessment of OSA. Sleep. 2011;34(3):363\u201370.","journal-title":"Sleep"},{"issue":"1","key":"2827_CR32","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1186\/1477-7525-11-207","volume":"11","author":"SI Isidoro","year":"2013","unstructured":"Isidoro SI, Salvaggio A, Bue AL, Romano S, Marrone O, Insalaco G. Quality of life in patients at first time visit for sleep disorders of breathing at a sleep centre. Health Qual Life Outcomes. 2013;11(1):207.","journal-title":"Health Qual Life Outcomes"},{"issue":"8","key":"2827_CR33","doi-asserted-by":"publisher","first-page":"1049","DOI":"10.1093\/sleep\/32.8.1049","volume":"32","author":"GE Silva","year":"2009","unstructured":"Silva GE, An M-W, Goodwin JL, Shahar E, Redline S, Resnick H, et al. Longitudinal evaluation of sleep-disordered breathing and sleep symptoms with change in quality of life: the Sleep Heart Health Study (SHHS). Sleep. 2009;32(8):1049\u201357.","journal-title":"Sleep"},{"issue":"6","key":"2827_CR34","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1093\/sleep\/14.6.540","volume":"14","author":"MW Johns","year":"1991","unstructured":"Johns MW. A new method for measuring daytime sleepiness: the Epworth Sleepiness Scale. Sleep. 1991;14(6):540\u20135.","journal-title":"Sleep"},{"key":"2827_CR35","volume-title":"Continuous positive airway pressure for the treatment of obstructive sleep apnoea\/hypopnoea syndrome: technology appraisal guidance [TA139]","author":"National Institute for Health and Care Excellence","year":"2008","unstructured":"National Institute for Health and Care Excellence. Continuous positive airway pressure for the treatment of obstructive sleep apnoea\/hypopnoea syndrome: technology appraisal guidance [TA139]. Published 26 March 2008. Updated 20 August 2021. Available from: https:\/\/www.nice.org.uk\/guidance\/ta139."},{"key":"2827_CR36","doi-asserted-by":"crossref","unstructured":"McDaid C, Griffin S, Weatherly H, Duree K, Van der Burgt M, Van Hout S, et al. Continuous positive airway pressure devices for the treatment of obstructive sleep apnoea-hypopnoea syndrome: a systematic review and economic analysis. Health Technol Assess. 2009;13(4).","DOI":"10.3310\/hta13040"},{"issue":"7","key":"2827_CR37","doi-asserted-by":"publisher","first-page":"1353","DOI":"10.5665\/sleep.5962","volume":"39","author":"LM Donovan","year":"2016","unstructured":"Donovan LM, Kapur VK. Prevalence and characteristics of central compared to obstructive sleep apnea: analyses from the Sleep Heart Health Study cohort. Sleep. 2016;39(7):1353\u20139.","journal-title":"Sleep"},{"issue":"2","key":"2827_CR38","doi-asserted-by":"publisher","first-page":"235","DOI":"10.5664\/jcsm.7624","volume":"15","author":"C Stepnowsky","year":"2019","unstructured":"Stepnowsky C, Sarmiento KF, Bujanover S, Villa KF, Li VW, Flores NM. Comorbidities, health-related quality of life, and work productivity among people with obstructive sleep apnea with excessive sleepiness: findings from the 2016 US National Health and Wellness Survey. J Clin Sleep Med. 2019;15(2):235\u201343.","journal-title":"J Clin Sleep Med"},{"issue":"10","key":"2827_CR39","doi-asserted-by":"publisher","first-page":"844","DOI":"10.1093\/sleep\/20.10.844","volume":"20","author":"M Johns","year":"1997","unstructured":"Johns M, Hocking B. Daytime sleepiness and sleep habits of Australian workers. Sleep. 1997;20(10):844\u20137.","journal-title":"Sleep"},{"key":"2827_CR40","volume-title":"The Epworth Sleepiness Scale","author":"MW Johns","year":"2020","unstructured":"Johns MW. The Epworth Sleepiness Scale. 2020. Available from: https:\/\/epworthsleepinessscale.com\/about-the-ess\/."},{"key":"2827_CR41","volume-title":"Epworth Sleepiness Scale","author":"British Lung Foundation","year":"2019","unstructured":"British Lung Foundation. Epworth Sleepiness Scale. 2019. Available from: https:\/\/www.blf.org.uk\/support-for-you\/obstructive-sleep-apnoea-osa\/diagnosis\/epworth-sleepiness-scale."},{"key":"2827_CR42","volume-title":"How should I assess a person with suspected obstructive sleep apnoea syndrome?","author":"National Institute for Health and Care Excellence","year":"2015","unstructured":"National Institute for Health and Care Excellence. NICE Clinical Knowledge Summary: How should I assess a person with suspected obstructive sleep apnoea syndrome? 2015. Available from: https:\/\/cks.nice.org.uk\/topics\/obstructive-sleep-apnoea-syndrome\/diagnosis\/assessment\/."},{"key":"2827_CR43","unstructured":"EuroQol Research Foundation. EQ-5D-5L | About. 2021. Available from: https:\/\/euroqol.org\/eq-5d-instruments\/eq-5d-5l-about\/."},{"issue":"5","key":"2827_CR44","doi-asserted-by":"publisher","first-page":"708","DOI":"10.1016\/j.jval.2012.02.008","volume":"15","author":"B Van Hout","year":"2012","unstructured":"Van Hout B, Janssen M, Feng Y-S, Kohlmann T, Busschbach J, Golicki D, et al. Interim scoring for the EQ-5D-5L: mapping the EQ-5D-5L to EQ-5D-3L value sets. Value Health. 2012;15(5):708\u201315.","journal-title":"Value Health"}],"container-title":["BMC Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12883-022-02827-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12883-022-02827-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12883-022-02827-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,25]],"date-time":"2022-08-25T11:13:59Z","timestamp":1661426039000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcneurol.biomedcentral.com\/articles\/10.1186\/s12883-022-02827-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8,25]]},"references-count":44,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["2827"],"URL":"https:\/\/doi.org\/10.1186\/s12883-022-02827-7","relation":{},"ISSN":["1471-2377"],"issn-type":[{"value":"1471-2377","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,8,25]]},"assertion":[{"value":"7 February 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 August 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 August 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The protocol and questionnaire for the 2016 and 2017 NHWS were reviewed and granted exemption by the Pearl Institutional Review Board (IRB) as it was determined this study met the exemption requirements under 45CFR46.101(b)(2). Informed consent was obtained from all respondents electronically.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"MJCM and VL are employees of Cerner Enviza, which received funding from Jazz Pharmaceuticals for study conduct and manuscript preparation. At the time of study conduct, JCR was an employee of Kantar Health, now Cerner Enviza, which received funding from Jazz Pharmaceuticals for study conduct and manuscript preparation. SM is an employee of Jazz Pharmaceuticals who, in the course of their employment, have received stock options exercisable for, and other stock awards of, ordinary shares of Jazz Pharmaceuticals plc. At the time of study conduct, JPCC was an employee of Jazz Pharmaceuticals who, in the course of their employment, received stock options exercisable for, and other stock awards of, ordinary shares of Jazz Pharmaceuticals plc.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"317"}}